We are live on ! Find out more
BC

Broadwood Capital Portfolio holdings

AUM $1.42B
1-Year Est. Return 34.72%
This Fund
S&P 500
This Quarter Est. Return
+0.15%
1 Year Est. Return
+34.72%
3 Year Est. Return
+45.97%
5 Year Est. Return
+44.27%
10 Year Est. Return
+866.96%
AUM
$800M
AUM Growth
-$16.7M
Cap. Flow
+$3.18M
Cap. Flow %
0.4%
Top 10 Hldgs %
100%
Holding
7
New
Increased
2
Reduced
Closed

Top Buys

Rank Stock Value
1
STAA icon
STAAR Surgical
STAA
+$2.89M
2
LCTX icon
Lineage Cell Therapeutics
LCTX
+$290K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 48.39%
2 Consumer Staples 37.34%
3 Industrials 6.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STAA icon
1
STAAR Surgical
STAA
$1.21B
$318M 39.82%
10,840,630
+100,000
+0.9% +$2.89M
MNST icon
2
Monster Beverage
MNST
$94.3B
$299M 37.34%
9,358,616
IWM icon
3
iShares Russell 2000 ETF
IWM
$79.8B
$65.3M 8.17%
420,000
AXON
4
Axon Enterprise
AXON
$42.5B
$48.8M 6.1%
760,062
LCTX icon
5
Lineage Cell Therapeutics
LCTX
$269M
$37.4M 4.67%
33,980,826
+251,835
+0.7% +$290K
IMDX
6
Insight Molecular Diagnostics
IMDX
$150M
$20.2M 2.52%
404,913
SER icon
7
Serina Therapeutics
SER
$30M
$11M 1.38%
85,219

Similar funds

Broadwood Capital's Q2 2019 Portfolio in Review

As of Q2 2019, Broadwood Capital held 7 positions worth $800M, down 2.1% from $817M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2019: portfolio turnover was 0%. Broadwood Capital opened no new positions and made no exits, leaving the 7-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, down from 56% a quarter earlier, followed by Consumer Staples and Industrials.

  • Broadwood Capital added most to STAAR Surgical in Q2 2019, an estimated $2.89M increase.
  • Broadwood Capital's ten largest holdings make up 100% of its $800M portfolio in Q2 2019.
  • Broadwood Capital opened 0 new positions and closed 0 in Q2 2019.
  • Broadwood Capital's portfolio value fell 2.1% quarter-over-quarter to $800M.

Based on Broadwood Capital's 13F filing for Q2 2019, filed 14 Aug 2019.